{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:55:54Z","timestamp":1790906154261,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["RTC-2017-6109-1"],"award-info":[{"award-number":["RTC-2017-6109-1"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s13311-021-01089-4","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T10:07:03Z","timestamp":1627898823000},"page":"1849-1861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1\u03b1 Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2"],"prefix":"10.1016","volume":"18","author":[{"given":"Mar\u00eda E.","family":"Prados","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Correa-S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Unciti-Broceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Garrido-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Jimenez-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Minassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Appendino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Calzado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-5842","authenticated-orcid":false,"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1570193X1103140915111559","article-title":"Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders","volume":"11","author":"Piotr","year":"2014","journal-title":"Mini Rev Org Chem"},{"key":"10.1007\/s13311-021-01089-4_bib2","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11101-019-09623-1","article-title":"Anna Horecka & Jacek Kurzepa Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential","volume":"18","author":"Anna Hordyjewska","year":"2019","journal-title":"Phytochemistry Reviews"},{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jnc.13243","article-title":"TGR5 signaling reduces neuroinflammation during hepatic encephalopathy","volume":"135","author":"McMillin","year":"2015","journal-title":"J Neurochem"},{"key":"10.1007\/s13311-021-01089-4_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.biopha.2016.11.028","article-title":"Betulinic acid protects against cerebral ischemia\/reperfusion injury by activating the PI3K\/Akt signaling pathway","volume":"84","author":"Jiao","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1007\/s13311-021-01089-4_bib5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.biopha.2017.09.028","article-title":"Betulinic acid protects the neuronal damage in new born rats from isoflurane-induced apoptosis in the developing brain by blocking FASL-FAS signaling pathway","volume":"95","author":"Wang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1007\/s13311-021-01089-4_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2018.05.015","article-title":"Betulinic acid, a natural PDE inhibitor restores hippocampal cAMP\/cGMP and BDNF, improve cerebral blood flow and recover memory deficits in permanent BCCAO induced vascular dementia in rats","volume":"832","author":"Kaundal","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.pharep.2017.11.020","article-title":"Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism","volume":"70","author":"Kaundal","year":"2018","journal-title":"Pharmacol Rep"},{"key":"10.1007\/s13311-021-01089-4_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fnmol.2018.00098","article-title":"Inhibitory Effects of Betulinic Acid on LPS-Induced Neuroinflammation Involve M2 Microglial Polarization via CaMKKbeta-Dependent AMPK Activation","volume":"11","author":"Li","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-021-01089-4_bib9","doi-asserted-by":"crossref","unstructured":"Xu, S.H., et al., New 30-norlupane derivatives through chemical-microbial semi-synthesis of betulinic acid and their neuroprotective effect. Bioorg Med Chem Lett, 2020. 30(17): p. 127407.","DOI":"10.1016\/j.bmcl.2020.127407"},{"issue":"10","key":"10.1007\/s13311-021-01089-4_bib10","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/acs.jnatprod.8b00514","article-title":"Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors","volume":"81","author":"Minassi","year":"2018","journal-title":"J Nat Prod"},{"key":"10.1007\/s13311-021-01089-4_bib11","doi-asserted-by":"crossref","unstructured":"Prados, M.E., et al., Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease. Acta Pharmacol Sin, 2020.","DOI":"10.1038\/s41401-020-0497-0"},{"issue":"2","key":"10.1007\/s13311-021-01089-4_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.10.005","article-title":"Advances in Hypoxia-Inducible Factor Biology","volume":"27","author":"Choudhry","year":"2018","journal-title":"Cell Metab"},{"issue":"7","key":"10.1007\/s13311-021-01089-4_bib13","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.celrep.2017.01.051","article-title":"The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1alpha Levels and Colorectal Cancer Cell Survival under Hypoxia","volume":"18","author":"Di Conza","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"10.1007\/s13311-021-01089-4_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCRESAHA.119.316071","article-title":"B55alpha\/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?","volume":"127","author":"Ehling","year":"2020","journal-title":"Circ Res"},{"key":"10.1007\/s13311-021-01089-4_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neuropharm.2018.03.009","article-title":"Huntingtin protein: A new option for fixing the Huntington's disease countdown clock","volume":"135","author":"Caterino","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1007\/s13311-021-01089-4_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cns.12828","article-title":"Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release","volume":"24","author":"Rebec","year":"2018","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"10.1007\/s13311-021-01089-4_bib17","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1212\/WNL.0b013e3181b2a719","article-title":"Hypoxia-induced mediators and neurologic disease","volume":"73","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-021-01089-4_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2013.01.026","article-title":"Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by \u201cantioxidant\u201d metal chelators: From ferroptosis to stroke","volume":"62","author":"Speer","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1471-4159.2005.03032.x","article-title":"Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells","volume":"93","author":"Yang","year":"2005","journal-title":"J Neurochem"},{"issue":"4","key":"10.1007\/s13311-021-01089-4_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/ars.2009.2800","article-title":"HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease","volume":"12","author":"Niatsetskaya","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1007\/s13311-021-01089-4_bib21","doi-asserted-by":"crossref","unstructured":"Li, H.S., et al., HIF-1alpha protects against oxidative stress by directly targeting mitochondria. Redox Biol, 2019. 25: p. 101109.","DOI":"10.1016\/j.redox.2019.101109"},{"issue":"1","key":"10.1007\/s13311-021-01089-4_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000127839","article-title":"Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia","volume":"82","author":"Chi","year":"2008","journal-title":"Pharmacology"},{"issue":"4","key":"10.1007\/s13311-021-01089-4_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/med.21477","article-title":"Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A \u201cstructure-activity relationship\u201d perspective","volume":"38","author":"Bhattarai","year":"2018","journal-title":"Med Res Rev"},{"issue":"19","key":"10.1007\/s13311-021-01089-4_bib24","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.1007\/s13311-021-01089-4_bib25","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00018-019-03309-9","article-title":"Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2","volume":"77","author":"Morrugares","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1007\/s13311-021-01089-4_bib26","doi-asserted-by":"crossref","unstructured":"Chiva, C., et al., QCloud: A cloud-based quality control system for mass spectrometry-based proteomics laboratories. PLoS One, 2018. 13(1): p. e0189209.","DOI":"10.1371\/journal.pone.0189209"},{"issue":"18","key":"10.1007\/s13311-021-01089-4_bib27","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","article-title":"Probability-based protein identification by searching sequence databases using mass spectrometry data","volume":"20","author":"Perkins","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1007\/s13311-021-01089-4_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4939-7057-5_23","article-title":"Efficient Quantitative Comparisons of Plasma Proteomes Using Label-Free Analysis with MaxQuant","volume":"1619","author":"Beer","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1007\/s13311-021-01089-4_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jprot.2013.10.023","article-title":"SAINTexpress: improvements and additional features in Significance Analysis of INTeractome software","volume":"100","author":"Teo","year":"2014","journal-title":"J Proteomics"},{"issue":"1","key":"10.1007\/s13311-021-01089-4_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ncb1816","article-title":"An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response","volume":"11","author":"Calzado","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1007\/s13311-021-01089-4_bib31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","article-title":"Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat","volume":"70","author":"Brouillet","year":"1998","journal-title":"J Neurochem"},{"issue":"4","key":"10.1007\/s13311-021-01089-4_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","article-title":"Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation","volume":"114","author":"Fernagut","year":"2002","journal-title":"Neuroscience"},{"issue":"5","key":"10.1007\/s13311-021-01089-4_bib33","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","article-title":"Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain","volume":"32","author":"Ito","year":"2001","journal-title":"Stroke"},{"key":"10.1007\/s13311-021-01089-4_bib34","doi-asserted-by":"crossref","unstructured":"Chen, S.D., et al., More Insight into BDNF against Neurodegeneration: Anti-Apoptosis, Anti-Oxidation, and Suppression of Autophagy. Int J Mol Sci, 2017. 18(3).","DOI":"10.3390\/ijms18030545"},{"issue":"1","key":"10.1007\/s13311-021-01089-4_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1602\/neurorx.1.1.26","article-title":"Hypoxic preconditioning protects against ischemic brain injury","volume":"1","author":"Sharp","year":"2004","journal-title":"NeuroRx"},{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-021-01089-4_bib37","doi-asserted-by":"crossref","unstructured":"Deepak Bhatia, M.S.A., Qiwen Shi and Shahrzad Movafagh, Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases, in Hypoxia and Human Diseases, C.Z. Jing Zheng, Editor 2017: Intechopen.","DOI":"10.5772\/66089"},{"issue":"9","key":"10.1007\/s13311-021-01089-4_bib38","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1007\/s11033-014-3444-7","article-title":"Neuroprotective role of BNIP3 under oxidative stress through autophagy in neuroblastoma cells","volume":"41","author":"Awan","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1007\/s13311-021-01089-4_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2019.05.016","article-title":"Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration","volume":"201","author":"Clark","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s13311-021-01089-4_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006907608230","article-title":"Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor","volume":"27","author":"Dobrogowska","year":"1998","journal-title":"J Neurocytol"},{"issue":"14","key":"10.1007\/s13311-021-01089-4_bib42","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1523\/JNEUROSCI.19-14-05731.1999","article-title":"Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system","volume":"19","author":"Sondell","year":"1999","journal-title":"J Neurosci"},{"issue":"3","key":"10.1007\/s13311-021-01089-4_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/JMN:14:3:197","article-title":"Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal","volume":"14","author":"Jin","year":"2000","journal-title":"J Mol Neurosci"},{"issue":"10","key":"10.1007\/s13311-021-01089-4_bib44","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/mt.2013.132","article-title":"Dose-dependent neuroprotection of VEGF(1)(6)(5) in Huntington's disease striatum","volume":"21","author":"Ellison","year":"2013","journal-title":"Mol Ther"},{"issue":"8","key":"10.1007\/s13311-021-01089-4_bib45","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-021-01089-4_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","article-title":"The Role of Microglia and Astrocytes in Huntington's Disease","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1007\/s13311-021-01089-4_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fncel.2015.00278","article-title":"Elusive roles for reactive astrocytes in neurodegenerative diseases","volume":"9","author":"Ben Haim","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1007\/s13311-021-01089-4_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pneurobio.2015.05.003","article-title":"Alternatively activated microglia and macrophages in the central nervous system","volume":"131","author":"Franco","year":"2015","journal-title":"Prog Neurobiol"},{"issue":"5\u20136","key":"10.1007\/s13311-021-01089-4_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1007\/s13311-021-01089-4_bib50","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144B","author":"Ciammola","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"10.1007\/s13311-021-01089-4_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol Res"},{"issue":"1","key":"10.1007\/s13311-021-01089-4_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":"Mitochondria in Huntington's disease","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochim Biophys Acta"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01089-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:41:40Z","timestamp":1761806500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923007754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1878747923007754"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01089-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1\u03b1 Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01089-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}